Skip to Content
Merck
  • Quantitative phase and polarization imaging through an optical fiber applied to detection of early esophageal tumorigenesis.

Quantitative phase and polarization imaging through an optical fiber applied to detection of early esophageal tumorigenesis.

Journal of biomedical optics (2019-12-17)
George S D Gordon, James Joseph, Maria P Alcolea, Travis Sawyer, Calum Williams, Catherine R M Fitzpatrick, Philip H Jones, Massimiliano di Pietro, Rebecca C Fitzgerald, Timothy D Wilkinson, Sarah E Bohndiek
ABSTRACT

Phase and polarization of coherent light are highly perturbed by interaction with microstructural changes in premalignant tissue, holding promise for label-free detection of early tumors in endoscopically accessible tissues such as the gastrointestinal tract. Flexible optical multicore fiber (MCF) bundles used in conventional diagnostic endoscopy and endomicroscopy scramble phase and polarization, restricting clinicians instead to low-contrast amplitude-only imaging. We apply a transmission matrix characterization approach to produce full-field en-face images of amplitude, quantitative phase, and resolved polarimetric properties through an MCF. We first demonstrate imaging and quantification of biologically relevant amounts of optical scattering and birefringence in tissue-mimicking phantoms. We present an entropy metric that enables imaging of phase heterogeneity, indicative of disordered tissue microstructure associated with early tumors. Finally, we demonstrate that the spatial distribution of phase and polarization information enables label-free visualization of early tumors in esophageal mouse tissues, which are not identifiable using conventional amplitude-only information.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N,N,N′,N′-Tetramethylethylenediamine, BioReagent, suitable for electrophoresis, ≥99.0%
Sigma-Aldrich
Ammonium persulfate, for molecular biology, suitable for electrophoresis, ≥98%
Sigma-Aldrich
Nigrosin, certified by the Biological Stain Commission
Sigma-Aldrich
Acrylamide/Bis-acrylamide, 30% solution, BioReagent, suitable for electrophoresis, 37.5:1
Sigma-Aldrich
Intralipid, 20%, emulsion